According to KYORIN Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.811317. At the end of 2023 the company had a P/S ratio of 0.8537.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.8537 | -5.68% |
2022 | 0.9051 | -7.11% |
2021 | 0.9744 | -9.47% |
2020 | 1.08 | 8.18% |
2019 | 0.9949 | -21.67% |
2018 | 1.27 | -8.35% |
2017 | 1.39 | -5.93% |
2016 | 1.47 | -6.59% |
2015 | 1.58 | 16.08% |
2014 | 1.36 | -5.08% |
2013 | 1.43 | 26.02% |
2012 | 1.14 | 15.93% |
2011 | 0.9796 | -12.2% |
2010 | 1.12 | 6.71% |
2009 | 1.05 |